Cargando…

Stem Cell Implants for Cancer Therapy: TRAIL-Expressing Mesenchymal Stem Cells Target Cancer Cells In Situ

PURPOSE: Tumor-specific delivery of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), an apoptosis-inducing peptide, at effective doses remains challenging. Herein we demonstrate the utility of a scaffold-based delivery system for sustained therapeutic cell release that capitalizes on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reagan, Michaela R., Seib, F. Philipp, McMillin, Douglas W., Sage, Elizabeth K., Mitsiades, Constantine S., Janes, Sam M., Ghobrial, Irene M., Kaplan, David L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Breast Cancer Society 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3468780/ https://www.ncbi.nlm.nih.gov/pubmed/23091539 http://dx.doi.org/10.4048/jbc.2012.15.3.273

Ejemplares similares

TRAIL-expressing mesenchymal stem cells kill the putative cancer stem cell population
por: Loebinger, M R, et al.
Publicado: (2010)

High-throughput approaches to discover novel immunomodulatory agents for cancer
por: McMillin, Douglas W., et al.
Publicado: (2012)

Systemic but not topical TRAIL-expressing mesenchymal stem cells reduce tumour growth in malignant mesothelioma
por: Sage, Elizabeth K, et al.
Publicado: (2014)

Cryopreservation of human mesenchymal stromal cells expressing TRAIL for human anti-cancer therapy
por: Yuan, Zhengqiang, et al.
Publicado: (2016)

Mesenchymal Stem Cells as Vectors for Lung Cancer Therapy
por: Kolluri, Krishna K., et al.
Publicado: (2013)

Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anti-cancer drug activity
por: McMillin, Douglas W., et al.
Publicado: (2010)

Behind the Adaptive and Resistance Mechanisms of Cancer Stem Cells to TRAIL
por: Quiroz-Reyes, Adriana G., et al.
Publicado: (2021)

Genetically modified mesenchymal stromal cells in cancer therapy
por: Sage, Elizabeth K., et al.
Publicado: (2016)

Chemo-Sensitization of CD133+ Cancer Stem Cell Enhances the Effect of Mesenchymal Stem Cell Expressing TRAIL in Non-Small Cell Lung Cancer Cell Lines
por: Fakiruddin, Kamal Shaik, et al.
Publicado: (2021)

Loss of functional BAP1 augments sensitivity to TRAIL in cancer cells
por: Kolluri, Krishna Kalyan, et al.
Publicado: (2018)

Stem cells are resistant to TRAIL receptor-mediated apoptosis
por: Szegezdi, Eva, et al.
Publicado: (2009)

Mesenchymal stem cells expressing TRAIL lead to tumour growth inhibition in an experimental lung cancer model
por: Mohr, Andrea, et al.
Publicado: (2008)

Site-Specific Integration of TRAIL in iPSC-Derived Mesenchymal Stem Cells for Targeted Cancer Therapy
por: Wang, Zujia, et al.
Publicado: (2022)

Oxaliplatin Enhances the Apoptotic Effect of Mesenchymal Stem Cells, Delivering Soluble TRAIL in Chemoresistant Colorectal Cancer
por: Quiroz-Reyes, Adriana G, et al.
Publicado: (2023)

Targeting of CD133+ Cancer Stem Cells by Mesenchymal Stem Cell Expressing TRAIL Reveals a Prospective Role of Apoptotic Gene Regulation in Non-Small Cell Lung Cancer
por: Shaik Fakiruddin, Kamal, et al.
Publicado: (2019)

Targeting lung cancer stem-like cells with TRAIL gene armed oncolytic adenovirus
por: Yang, Yu, et al.
Publicado: (2015)

Mesenchymal Stem Cell Expressing TRAIL as Targeted Therapy against Sensitised Tumour
por: Shaik Fakiruddin, Kamal, et al.
Publicado: (2018)

Mesenchymal stem cells enhance the oncolytic effect of Newcastle disease virus in glioma cells and glioma stem cells via the secretion of TRAIL
por: Kazimirsky, Gila, et al.
Publicado: (2016)

Trailing TRAIL Resistance: Novel Targets for TRAIL Sensitization in Cancer Cells
por: Trivedi, Rachana, et al.
Publicado: (2015)

Can Weather Influence the Prevalence of Acute-on-chronic Liver Failure?
por: McMillin, Matthew
Publicado: (2019)

STAT3, stem cells, cancer stem cells and p63
por: Galoczova, Michaela, et al.
Publicado: (2018)

Sulforaphane and TRAIL induce a synergistic elimination of advanced prostate cancer stem-like cells
por: LABSCH, SABRINA, et al.
Publicado: (2014)

Regenerating human epithelia with cultured stem cells: feeder cells, organoids and beyond
por: Hynds, Robert E, et al.
Publicado: (2017)

Adipose-derived mesenchymal stem cell-facilitated TRAIL expression in melanoma treatment in vitro
por: JING, HAI XIA, et al.
Publicado: (2016)

Letter to the Editor on “Mesenchymal stem cells enhance the oncolytic effect of Newcastle disease virus in glioma cells and glioma stem cells via the secretion of TRAIL”
por: Liu, Mingli
Publicado: (2017)

Engineered human mesenchymal stem cells for neuroblastoma therapeutics
por: Nieddu, Valentina, et al.
Publicado: (2019)

Evaluating the Effect of Therapeutic Stem Cells on TRAIL Resistant and Sensitive Medulloblastomas
por: Nesterenko, Irina, et al.
Publicado: (2012)

Triamcinoline acetonide (kenalog) in treatment of cases of hay fever and its effect on pituitary-adrenal axis.
por: McMillin, W. P.
Publicado: (1971)

Quality Improvement Innovation in a Maternal and Child Health Network: Negotiating Course Corrections in Mid-Implementation
por: McMillin, Stephen Edward
Publicado: (2020)

Generation of magnetic biohybrid microrobots based on MSC.sTRAIL for targeted stem cell delivery and treatment of cancer
por: Gundersen, Rebekah Anamarie, et al.
Publicado: (2023)

Potential Role of CD133 Expression in the Susceptibility of Human Liver Cancer Stem-Like Cells to TRAIL
por: Lee, Su-Hoon, et al.
Publicado: (2016)

The Combination of TRAIL Treatment and Cancer Cell Selective Expression of TRAIL-Death Receptor DR4 Induces Cell Death in TRAIL-Resistant Cancer Cells
por: Choi, Eunah, et al.
Publicado: (2006)

Stemness in Cancer: Stem Cells, Cancer Stem Cells, and Their Microenvironment
por: Aponte, Pedro M., et al.
Publicado: (2017)

Myeloma cells inhibit osteogenic differentiation of mesenchymal stem cells and kill osteoblasts via TRAIL-induced apoptosis
por: Fu, Jinxiang, et al.
Publicado: (2010)

Microenvironmental Influence on Pre-Clinical Activity of Polo-Like Kinase Inhibition in Multiple Myeloma: Implications for Clinical Translation
por: McMillin, Douglas W., et al.
Publicado: (2011)

JNK pathway inhibition selectively primes pancreatic cancer stem cells to TRAIL-induced apoptosis without affecting the physiology of normal tissue resident stem cells
por: Recio-Boiles, Alejandro, et al.
Publicado: (2016)

Concise Review: Cancer Cells, Cancer Stem Cells, and Mesenchymal Stem Cells: Influence in Cancer Development
por: Papaccio, Federica, et al.
Publicado: (2017)

NK Cells Can Preferentially Target Prostate Cancer Stem-like Cells via the TRAIL/DR5 Signaling Pathway
por: Seki, Taiga, et al.
Publicado: (2021)

Analysis of mesenchymal stem cell proteomes in situ in the ischemic heart
por: Han, Dunzheng, et al.
Publicado: (2020)

Human Embryonic Stem Cells Acquire Responsiveness to TRAIL upon Exposure to Cisplatin
por: Pešková, Lucie, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_61ecmfjmoq51nrade470c5cvpt